Skip to main content
. Author manuscript; available in PMC: 2011 Sep 14.
Published in final edited form as: Nephrol Nurs J. 2010 May-Jun;37(3):271–281.

Table 5.

Correlational Matrix of Key Variables (N = 151)

Variables 1 2 3 4 5 6 7 8 9 10 11 12
1. Age
2. Comorbidity 0.421**
3. HD Vintage 0.031 −0.221**
4. Treatment Controla 0.156 0.000 0.086
5. Adherence to HD 0.297** 0.123 0.005 −0.024
6. Adherence to Medications 0.227** 0.066 0.133 −0.054 0.225**
7. Adherence to Fluid 0.111 −0.014 −0.009 0.038 0.136 0.150
8. Adherence to Diet −0.001 −0.023 −0.081 −0.171* 0.162* 0.207* 0.303**
9. IDWG for 4 Weeks 0.013 0.213** 0.106 0.065 0.162* −0.044 −0.205* −0.141
10. Kt/Vurea, Single Pool 0.092 −0.142 0.257** 0.095 0.169* 0.154 −0.010 0.069 −0.246**
11. Pre-HD Serum Phosphrus −0.274** −0.096 −0.176* 0.034 −0.154 −0.272** 0.042 −0.055 0.178* −0.279**
12. Pre-HD Serum Potassium −0.224** −0.041 −0.023 −.064 −0.115 −0.020 −0.040 −0.051 0.221** −0.084 0.111
13. Post-HD SUN −0.075 0.201* −0.249** 0.077 −0.161* −0.120 −0.096 −0.106 0.416** −0.661** 0.348** 0.305**
a

Treatment control = score of treatment control dimension among 7 dimensions of illness perception’s control dimension; co-morbidity = Charlson comorbidity scores were used; higher illness perception scores reflect stronger negative perceptions about illness; higher adherence scores reflect better adherence level.

*

Correlation is significant at the 0.05 level (2-tailed).

**

Correlation is significant at the 0.01 level (2-tailed).